It adds that when starting an adult with T2DM on dual therapy with metformin and an SGLT2 inhibitor, the drugs should be introduced sequentially, starting with metformin, to check tolerability.Orforglipron offers greater weight loss for people with diabetes than oral semaglutide.
In phase 3 trials, triple therapy with dapagliflozin (an SGLT-2 inhibitor), saxagliptin (a DPP-4 inhibitor) and metformin reduced 24-week HbA1c to a greater extent than dual therapy with dapagliflozin or saxagliptin in combination with metformin.
How they work. Weight-loss drugs work by suppressing an individual's appetite by mimicking hormones that tell our body when it is full. The most common are known as glucagon-like peptide 1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP.
Sulfonylureas have been the preferred add-on therapy to metformin for T2DM, but a study finds that DPP-4s have lower risks of death, CV events, and hypoglycemia. PRACTICE CHANGER.
In part 2, empagliflozin and metformin dual therapy or the abovementioned triple therapy were administered for 5 days. Serial blood samples were collected up to 24 hours after the last dose in each period for PK evaluation.
Many South Africans using GLP-1 medications for weight management are paying privately because most medical aids still classify these treatments as non-essential or lifestyle-related. For patients, the injection format can also feel intimidating or inconvenient long term.
